News/Publications/Press

01 Apr 2019

Epimune appoints Dr. Uwe Staub as Chief Executive Officer (CEO) 

Dr. Staub has 25 years of experience in the in-vitro diagnostic (IVD) industry. Before joining Epimune, he was part of Epigenomics' executive team, and held senior management positions at Qiagen, Digene and Abbott

2018

01 Dec 2018

Epimune joins the "DC4Balance" Consortium - a Health~Holland funded Public-Private-Partnership targeting dendritic cells for resetting immune balance in autoimmune diseases, allergy and cancer (see video interview with Project Coordinator Prof. Dr. Jolanda de Vries) 

01 Dec 2018

Coverage of epigenetic immune cell quantification technology development supported by Federal Ministry of Education and Research (BMBF Newsletter; German only)

01 Aug 2018

Seminal publication on epigenetic immune cell quantification published by Epiontis in Science Translational Medicine

 

(...) Baron et al. took advantage of distinct immune cell epigenetic signatures and devised a real-time quantitative polymerase chain reaction (qPCR) method to perform immune cell counting without the requirement of viable cells. They examined different types of samples from healthy adults or those that were infected with HIV (and consequently had fewer CD4+ T cells). The epigenetic qPCR method correlated well with flow cytometry and could also be applied to dried blood spots to identify newborns with primary immunodeficiencies. (...)

 

Upcoming Events

25-27 April 2019

"Tumor Immunology Meets Oncology XV" Workshop & Symposium (Martin-Luther-University Halle-Wittenberg, Institute of Medical Immunology, Prof. Dr. Barbara Seliger)

  • Epimune's Christoph Sachsenmaier will present "Epigenetic immune cell quantification - a novel approach for minimally invasive immune cell profiling"

08-09 May 2019

BioVaria 2019 (Munich)

  • Epimune selected as "Startup 2019" company
  • This unique event brings together innovators from universities, research institutes and startups with Europe’s leading tech transfer professionals, investors and global biopharmaceutical industry

14-17 May 2019

The 81st China International Medical Equipment Fair (CMEF Spring 2019) (National Exhibition and Convention Center Shanghai)

  • Epimune will exhibit at the CMEF Spring 2019 together with companies from the Diagnostik Network Berlin-Brandenburg
  • Find us in Hall 3, Booth No. 3D27 - within the "International IVD" Section of the exhibition

18-21 June 2019

Federation of Clinical Immunology Societies - FOCIS 2019 (Boston, MA)

  • Poster presentation by Epimune's Janika Schulze
  • Abstract 627388, titled “Comprehensive Epigenetic Immune Cell Monitoring in Diverse Clinical Applications

Past Events (2019)

10-15 Mar 2019

26th International Molecular Med Tri-Con (San Francisco, CA)

04-07 Apr 2019

Clinical Immunology Society (CIS) 2019 Annual Meeting (Atlanta, GA)